Disease burden of Group B streptococcus among infants in Sub-Saharan Africa

Pediatric Infectious Disease Journal

Volumn 35, Issue 9, 2016, Pages 933-942

  Sinha, Anushua ^a   Russell, Louise B ^b   Tomczyk, Sara ^c   Verani, Jennifer R ^c   Schrag, Stephanie J ^c   Berkley, James A ^d,e   Mohammed, Musa ^f   Sigauque, Betuel ^g   Kim, Sun Young ^h  

^a RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f HAWASSA UNIVERSITY   (Ethiopia)

^g Manhiça Health Research Center   (Mozambique)

^h UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Africa; global health; group B streptococcus; meta analysis; neonatal meningitis; neonatal sepsis

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BACTERIAL COLONIZATION; CONFIDENCE INTERVAL; EVIDENCE BASED PRACTICE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFANT DISEASE; MATERNAL EXPOSURE; META ANALYSIS; MORBIDITY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; SYSTEMATIC REVIEW; FEMALE; HETEROZYGOTE; INFANT; MENINGITIS; NEWBORN; NEWBORN DISEASE; NEWBORN SEPSIS; PREGNANCY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS VACCINE;

AFRICA SOUTH OF THE SAHARA; CARRIER STATE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MENINGITIS; NEONATAL SEPSIS; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE;

EID: 84983472727     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001233     Document Type: Review

References (43)

1. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and metaanalysis. Lancet. 2012; 379: 547-556
2. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-Revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59(RR-10): 1-36
3. Novartis Vaccines (Novartis). Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings. Available at: https://clinicaltrials.gov/show/NCT01412801. Accessed September 9, 2015
4. Novartis Vaccines (Novartis). A Phase Ib/II Randomized, Observer-blind, Controlled, Single Centre Study of a Trivalent Group B Streptococcus Vaccine in Healthy Non-pregnant Women Leading Into a Dose-ranging Study in Pregnant Women in South Africa. Available at: https://clinicaltrials.gov/show/NCT01193920. Accessed September 9, 2015
5. Kim SY, Russell LB, Park J, et al. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014; 32: 1954-1963
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339: b2700
7. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012
8. Wallace BC, Dahabreh IJ, Trikalinos TA, et al. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012; 49: 1-15
9. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, England: Wiley-Blackwell; 2008
10. Gray KJ, Kafulafula G, Matemba M, et al. Group B streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis. 2011; 17: 1932-1935
11. Cutland CL, Madhi SA, Zell ER, et al. PoPS Trial Team. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009; 374: 1909-1916
12. de Steenwinkel FD, Tak HV, Muller AE, et al. Low carriage rate of group B streptococcus in pregnant women in Maputo, Mozambique. Trop Med Int Health. 2008; 13: 427-429
13. Osman NB, Folgosa E, Bergström S. An incident case-referent study of threatening preterm birth and genital infection. J Trop Pediatr. 1995; 41: 267-272
14. Kwatra G, Madhi SA, Cutland CL, et al. Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B streptococcus in vaginal and rectal swabs from pregnant women in South Africa. J Clin Microbiol. 2013; 51: 2515-2519
15. Mavenyengwa RT, Afset JE, Schei B, et al. Group B streptococcus colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet Gynecol Scand. 2010; 89: 250-255
16. Moyo SR, Mudzori J, Tswana SA, et al. Prevalence, capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent Afr J Med. 2000; 46: 115-120
17. Thinkhamrop J, Limpongsanurak S, Festin MR, et al. Infections in international pregnancy study: Performance of the optical immunoassay test for detection of group B streptococcus. J Clin Microbiol. 2003; 41: 5288-5290
18. Suara RO, Adegbola RA, Baker CJ, et al. Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis. 1994; 170: 1316-1319
19. Mosabi JM, Arimi SM, Kang?ethe EK. Isolation and characterization of group B streptococci from human and bovine sources within and around Nairobi. Epidemiol Infect. 1997; 118: 215-220
20. Joachim A, Matee MI, Massawe FA, et al. Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009; 9: 437
21. Uhiara JE. Group B streptococcal carriage among parturients and their neonates in Zaria, Nigeria. Afr J Med Med Sci. 1993; 22: 79-83
22. Dzowela T, Komolafe OO, Igbigbi A. Prevalence of group B streptococcus colonization in antenatal women at the Queen Elizabeth Central Hospital, Blantyre-A preliminary study. Malawi Med J. 2005; 17: 97-99
23. Mohammed M, Asrat D, Woldeamanuel Y, et al. Prevalence of group B streptococcus colonization among pregnant women attending antenatal clinic of Hawassa Health Center, Hawassa, Ethiopia. Ethiop J Health Dev. 2012; 26: 36-42
24. Mavenyengwa RT, Masunga P, Meque E, et al. Streptococcus agalactiae (group B streptococcus (GBS)) colonisation and persistence, in pregnancy; a comparison of two diverse communities (rural and urban). Cent Afr J Med. 2006; 52: 38-43
25. Madhi SA, Radebe K, Crewe-Brown H, et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003; 23: 15-23
26. Haffejee IE, Bhana RH, Coovadia YM, et al. Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa. J Infect. 1991; 22: 225-231
27. Bomela HN, Ballot DE, Cooper PA. Is prophylaxis of early-onset group B streptococcal disease appropriate for South Africa?. S Afr Med J. 2001; 91: 858-860
28. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005; 352: 39-47
29. Gray KJ, Bennett SL, French N, et al. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis. 2007; 13: 223-229
30. Ojukwu JU, Abonyi LE, Ugwu J, et al. Neonatal septicemia in high risk babies in South-Eastern Nigeria. J Perinat Med. 2006; 34: 166-172
31. Madzivhandila M, Adrian PV, Cutland CL, et al. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One. 2011; 6: e17861
32. Kwatra G, Cunnington MC, Valencia C, et al. Maternal colonization with group B streptococcus: Do rates vary across regions?. In: 8th World Congress of the World Society for Pediatric Infectious Diseases. Cape Town, South Africa; November 19-22, 2013
33. Nathoo KJ, Mason PR, Chimbira TH. Neonatal septicaemia in Harare Hospital: aetiology and risk factors. The Puerperal Sepsis Study Group. Cent Afr J Med. 1990; 36: 150-156
34. Katherine JG, Sally LB, Neil F, et al. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis. 2007; 13: 223
35. Milledge J, Calis JC, Graham SM, et al. Aetiology of neonatal sepsis in Blantyre, Malawi: 1996-2001. Ann Trop Paediatr. 2005; 25: 101-110
36. Sigaúque B, Roca A, Mandomando I, et al. Community-Acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J. 2009; 28: 108-113
37. Edwards MS, Nizet V. Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, eds. Infectious Diseases of the Fetus and Newborn. 7th ed. Philadelphia, PA: Elsevier Saunders; 2011: 419-469
38. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999; 103: e77
39. Davies HD, Adair C, McGeer A, et al. Antibodies to capsular polysaccharides of group B streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis. 2001; 184: 285-291
40. Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008. Emerg Infect Dis. 2015; 21
41. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013; 31(suppl 4): D7-12
42. Lawn JE, Blencowe H, Oza S, et al. Lancet Every Newborn Study Group. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014; 384: 189-205
43. Bhutta ZA, Das JK, Bahl R, et al. Lancet Newborn Interventions Review Group. Lancet Every Newborn Study Group. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. Lancet. 2014; 384: 347-370